With evidence of AGI-5198 decreasing D-2HG production and suppressing the mutant IDH1 enzyme activity in chondrosarcoma cells, we next assessed whether this translated into inhibition of cell growth and tumorigenic activity. The gene discussed is IDH1; the disease is chondrosarcoma.